CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Total net revenue	$ 100,806	$ 78,946	$ 186,324	$ 157,624
Operating expenses:
Research and development	38	559	87	559
General and administrative	4,228	2,596	10,214	5,159
Total operating expenses	4,266	3,155	10,301	5,718
Income from operations	96,540	75,791	176,023	151,906
Other income (expense), net	(951)	30	(1,384)	98
Interest income	20	158	50	1,460
Interest expense	(4,745)	(4,561)	(9,439)	(9,077)
Changes in fair values of equity and long-term investments, net	45,315	46,698	100,360	68,613
Income before income taxes	136,179	118,116	265,610	213,000
Income tax expense, net	25,333	19,891	45,069	35,823
Net income	110,846	98,225	220,541	177,177
Net income attributable to noncontrolling interest	21,898	21,381	37,470	34,896
Net income attributable to Innoviva stockholders	$ 88,948	$ 76,844	$ 183,071	$ 142,281
Basic net income per share attributable to Innoviva stockholders	$ 1.01	$ 0.76	$ 1.93	$ 1.40
Diluted net income per share attributable to Innoviva stockholders	$ 0.90	$ 0.69	$ 1.73	$ 1.27
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	88,423	101,324	94,858	101,280
Shares used to compute diluted net income per share	100,639	113,545	107,096	113,527
Royalty revenue from a related party
Total net revenue	$ 100,806	$ 68,946	$ 186,324	$ 147,624
Revenue from collaborative arrangements with a related party
Total net revenue	$ 0	$ 10,000	$ 0	$ 10,000